Skip to Main Content
Skip Nav Destination

Anti-Transforming Growth Factor-β2 Antibody (CAT-152) as a New Post-Operative Modulator of Scarring after Experimental Glaucoma Filtration Surgery

Clin Sci (Lond) (2003) 104 (s49): 61P.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal